ESCO v CQMS – earth moving assemblies – numerous matters in the Federal Court and IP Australia.
Mylan v Sun Pharma – the lipid lowering drug Lipidil – Federal Court.
Merck v BMS – biologic-based treatment of melanoma relevant to Merck’s Keytruda and Nivolumab biologics – Federal Court.
BMS – patent extension of term relevant to Nivolumab before IP Australia.
Hospira/Pfizer v Janssen in the Administrative Appeal Tribunal concerning the regulatory consequences of the “A” flagging of biosimilar Inflectra by the PBAC.
Watson Pharma & Ascent Pharma (Actavis) v AstraZeneca – rosuvastatin (Crestor) – Federal Court and High Court.
Hospira v Novartis – zoledronic acid – Federal Court.
Medrad Inc (and Imaxeon) v Alpine Medical – syringes – Federal Court.
Abbott Laboratories v Apotex – the weight-loss drug Reductil – Federal Court.
Sanofi-Aventis v Hospira – cancer drug docetaxel – Federal Court.
ResMed Limited v Anaesthetic Supplies Pty Limited – CPAP medical devices – Federal Court.
Bristol Myers Squibb v F H Faulding & Co Limited – anti cancer drug TAXOL – Federal Court.
Welcome Real-Time v Catuity – business method patent for a loyalty card – Federal Court.
Photocure v Queens University – photo activated skin cancer substance – Federal Court.